Solvotrin is a privately held healthcare and medicine development company.

With Enterprise Ireland “High Potential Start Up” (HPSU) status and funding to date, Solvotrin has taken its healthcare and medicine portfolio to an advanced stage of development. Solvotrin will launch its first supplement product on the UK and Ireland market in 2016.

The company will further develop licensing/distribution arrangements to enable a broader access to other markets and further develop its pipeline portfolio.

For more information please email: